Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade? (2023)
- Authors:
- USP affiliated authors: LAGE, LUIS ALBERTO DE PADUA COVAS - FM ; PEREIRA, JULIANA - FM
- Unidade: FM
- DOI: 10.3389/fonc.2023.1175545
- Subjects: LINFOMA; HERPESVIRUS 4 HUMANO; RESISTÊNCIA MICROBIANA ÀS DROGAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in oncology
- ISSN: 2234-943X
- Volume/Número/Paginação/Ano: v. 13, article ID 1175545, 17p, 2023
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
COSTA, Renata de Oliveira et al. Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?. Frontiers in oncology, v. 13, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54568. Acesso em: 31 dez. 2025. -
APA
Costa, R. de O., Pereira, J., Lage, L. A. de P. C., & Baiocchi, O. C. G. (2023). Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade? Frontiers in oncology, 13. doi:10.3389/fonc.2023.1175545 -
NLM
Costa R de O, Pereira J, Lage LA de PC, Baiocchi OCG. Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade? [Internet]. Frontiers in oncology. 2023 ; 13[citado 2025 dez. 31 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54568 -
Vancouver
Costa R de O, Pereira J, Lage LA de PC, Baiocchi OCG. Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade? [Internet]. Frontiers in oncology. 2023 ; 13[citado 2025 dez. 31 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54568 - Análise do perfil de expressão de genes de proliferação/regulação celular, resposta inflamatória e angiogênese e do padrão de metilação dos genes p15INK4b e p16INK4a em portadores de linfoma de células T periféricas
- Expression of CysLTR1 and 2 in Maturating Lymphocytes of Hyperplasic Tonsils Compared to Peripheral Cells in Children
- Macrophage migration inhibitory factor and chemokine RANTES in young pediatric patients with congenital cardiac communications: relation to hemodynamic parameters and the presence of Down syndrome
- CD4+ lymphocytes in asymptomatic HTLV-1 carriers present cell cycle arrest in GO/G1 phase
- Time-to-treatment of diffuse large B-cell lymphoma in São Paulo
- Bortezomib (Btz) dose intensity is the strongest predictor for overall survival (OS) in mantle cell lymphoma (MCL) patients (Pts) not considered for transplantation, receiving frontline Btz plus rituximab, cyclosphosphamide, doxorubicin, and prednisone (VR-CAP) therapy in the phase 3 LYM 3002 study
- Immune reconstitution inflammatory syndrome-associated lymphoma: a retrospective Brazilian cohort
- Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances
- Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma
- Comparison between R-CHOP vs R-CHOP plus etoposide in untreated patients with primary mediastinal B-cell lymphoma: Preliminary findings
Informações sobre o DOI: 10.3389/fonc.2023.1175545 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
